Treatment to Target Using Recombinant Interleukin-1 Receptor Antagonist as First-Line Monotherapy in New-Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five-Year Follow-Up Study
以重组白细胞介素-1受体拮抗剂作为一线单药疗法治疗新发全身型幼年特发性关节炎:一项为期五年的随访研究结果
期刊:Arthritis & Rheumatology
影响因子:10.9
doi:10.1002/art.40865
Ter Haar, Nienke M; van Dijkhuizen, E H Pieter; Swart, Joost F; van Royen-Kerkhof, Annet; El Idrissi, Ayman; Leek, Arjen P; de Jager, Wilco; de Groot, Mark C H; Haitjema, Saskia; Holzinger, Dirk; Foell, Dirk; van Loosdregt, Jorg; Wulffraat, Nico M; de Roock, Sytze; Vastert, Sebastiaan J